Filing Details
- Accession Number:
- 0001209191-18-053219
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2018-10-02 16:43:03
- Reporting Period:
- 2018-10-01
- Accepted Time:
- 2018-10-02 16:43:03
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1294133 | Inogen Inc | INGN | Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842) | 000000000 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1596103 | Brenton Taylor | C/O Inogen, Inc. 326 Bollay Drive Goleta CA 93117 | Evp, Engineering | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2018-10-01 | 5,000 | $16.62 | 41,297 | No | 4 | A | Direct | |
Common Stock | Disposition | 2018-10-01 | 1,311 | $243.15 | 39,986 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-10-01 | 1,080 | $243.76 | 38,906 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-10-01 | 1,268 | $245.62 | 37,638 | No | 4 | S | Direct | |
Common Stock | Disposition | 2018-10-01 | 1,341 | $246.36 | 36,297 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | A | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option (Right to Buy) | Disposition | 2018-10-01 | 5,000 | $0.00 | 5,000 | $16.62 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
55,311 | 2021-03-31 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
---|---|---|---|
Common Stock | 842 | Indirect | By Spouse |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2017.
- Represents the weighted average share price of an aggregate total of 1,311 shares sold in the price range of $242.42 to $243.33 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 1,080shares sold in the price range of $243.52 to $244.29 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 1,268 shares sold in the price range of $245.13 to $246.115 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
- Represents the weighted average share price of an aggregate total of 1,341shares sold in the price range of $246.18 to $246.60 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price
- Subject to the reporting person's continuing service, 1/48th of the total shares subject to the option shall vest every month after March 1, 2014